We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

February 9, 2023

5 Expert Insights from the HealthXL Community

Commentary
HealthXL Team & Community

Over the past month, our HealthXL community members have discussed the opportunities for digital health in retail healthcare, using real-world data (RWD) to increase market access and revenue generation in DTx partnerships among other topics. We’ve put together a snapshot of expert insights from these meetings. 

#1 On RWD and clinical trial data: 

Traditionally, clinical trial data is favored over retrospective RWD. However, using retrospective RWD can eliminate the need for control groups, reduce risks to patients, and reduce costs. Data from clinical evidence and real-world trials should be used to complement each other, for validation purposes. There is more flexibility in RWD collection, which can create an opportunity to study a wider cohort and better inform economic evidence compared to clinical trials that are highly controlled. As with all study designs, a reduction in bias is key to gathering accurate information through both clinical trials and RWD. 

#2 On the revenue model that works for pharma-DTx partnerships: 

Offering a DTx solution for free can attract patients, and allows pharma companies to buy space on the DTx platform for ethical promotion and patient engagement. Alternatively, pharma companies can link revenue to the DTx partnership, if user numbers are large enough. Some regulatory bodies will also give the option of a patent extension for tech plus molecular therapies which have shown better outcomes. This can support a conversation with payers and get price protection. 

#3 On moving from DTx point solutions to platforms: 

Transitioning from point solutions to platforms in DTx can expand the technology's scope and capabilities to address a broader range of medical conditions and patient needs. This can be achieved by integrating multiple DTx solutions into one platform and adding features to support a wider range of user needs. Additionally, it is important to prioritize regulatory requirements, privacy, and security of the operating system.

#4 Digital health for trigger management in autoimmune conditions: 

Digital health tools are becoming more sophisticated in their ability to identify triggers, reducing the time to diagnosis and treatment. This is especially relevant for autoimmune conditions, many of which are difficult to diagnose and track, and where early diagnosis is key to improving treatment options. Utilizing digital tools can alleviate the HCP burden, as well as incentivize patients toward medication adherence, reducing hospitalization and improving the quality of life for patients. For pharma, these digital tools provide an opportunity to develop combination tools to add to their product catalog and give pharma more ownership over the patient journey.

#5 On how DTx companies can navigate FDA Breakthrough Designation: 

Once the DTx solution is developed and the target population is identified, the reimbursement strategy can be determined. It is important to identify the reimbursement strategy early in the process, to ensure that evidence is generated in a way that satisfies the expectations of both payers and regulators. For Breakthrough Designation to be granted, there needs to be evidence that it ‘could’ more effectively treat or diagnose compared to current devices, whereas 510k approval requires evidence that the device is ‘as effective’ as another FDA approved device. 



Join our HealthXL platform to keep up-to-date on the latest digital health news and join virtual and in-person events.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

No upcoming Virtual Events scheduled. Please check back again soon.

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

2nd April 2024 @ 11am ET

Where is Gen AI generating ROI?

The buzz surrounding AI's role in healthcare is undeniable.
Dave Peak
Featuring
Dave Peak
Investor, EasyBee AI

RPM for Oncology: Data Collection

Remote patient monitoring (RPM) is a key component of digital health, especially in the field of oncology.
Featuring
04TH APRIL 2024 @ 11AM ET

Patient & Site Engagement: How Can Technology Improve Trial Experiences

In the dynamic landscape of clinical trials, technology stands as a transformative force, reshaping patient and site engagement for the better.

Meri Beckwith
Featuring
Meri Beckwith
Co-Founder at Lindus Health
9th April 2024 @ 11am ET

How Digital Diagnostics Enable Precision Medicine

The acceleration of advanced analytics, propelled by artificial intelligence and Big Data, is expanding possibilities to unlock the power of collected data.

Dr Kamala Maddali
Featuring
Dr Kamala Maddali
President and Founder, Health Collaborations LLC

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.